Revolution Medicines Inc (RVMD)
38.85
-0.20
(-0.51%)
USD |
NASDAQ |
May 07, 16:00
38.87
+0.02
(+0.05%)
After-Hours: 20:00
Revolution Medicines Cash from Financing (Quarterly): 839.35M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 839.35M |
| September 30, 2023 | 1.011M |
| June 30, 2023 | 64.63M |
| March 31, 2023 | 324.20M |
| December 31, 2022 | 51.36M |
| September 30, 2022 | 248.34M |
| June 30, 2022 | 1.429M |
| March 31, 2022 | 0.305M |
| December 31, 2021 | 10.73M |
| September 30, 2021 | 0.319M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.868M |
| March 31, 2021 | 282.26M |
| December 31, 2020 | 1.485M |
| September 30, 2020 | 168.88M |
| June 30, 2020 | -1.336M |
| March 31, 2020 | 253.74M |
| December 31, 2019 | -1.534M |
| September 30, 2019 | 10.00M |
| June 30, 2019 | 90.17M |
| March 31, 2019 | 0.014M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.534M
Minimum
Dec 2019
839.35M
Maximum
Dec 2023
123.49M
Average
10.73M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Cutera Inc | -0.232M |
| BioSig Technologies Inc | 2.747M |
| TRACON Pharmaceuticals Inc | 1.324M |
| Zentalis Pharmaceuticals Inc | 0.00 |
| Day One Biopharmaceuticals Inc | 0.048M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -120.56M |
| Cash from Investing (Quarterly) | -380.40M |
| Free Cash Flow | -358.30M |
| Free Cash Flow Per Share (Quarterly) | -0.8685 |
| Free Cash Flow to Equity (Quarterly) | -122.88M |
| Free Cash Flow to Firm (Quarterly) | -122.88M |
| Free Cash Flow Yield | -8.15% |